Q3FY18 Results: Eris Lifesciences PAT jumps 10 per cent YoY Q3FY18 Results: Eris Lifesciences PAT jumps 10 per cent YoY Nidhi Jani / Monday, February 12, 2018 0 1975 Article rating: 5.0 The PAT for the quarter came in at Rs. 74.92 crore, yoy increase of 10 per cent. This was due to decline in effective tax rate from 5 to 3 per cent in Q3FY18. Read more
Q3FY18 Results: PAT of Kwality melts by 53.6 per cent Q3FY18 Results: PAT of Kwality melts by 53.6 per cent Amir Shaikh / Monday, February 12, 2018 0 3125 Article rating: 5.0 The PAT for the quarter came in at Rs. 20.93 crore, yoy decline of 53.6 per cent. This was due to sharp decline in other income to Rs. 0.22 crore as against Rs. 5.03 crore in corresponding quarter of last year. Read more
Behavioural biases that impact your Investment decisions Behavioural biases that impact your Investment decisions Nikhil Desai / Monday, February 12, 2018 0 3474 Article rating: 5.0 Irrespective of what asset classes you favour more, your behavioural tendencies will always play a great role in your success or failure as an investor. It's strange but true that the behavioural traps do impact your investment decision and wealth creations. Here are some behavioural traps/biases which should be avoided by mutual fund investors in the upcoming year. Read more
Q3FY18 Results: Va Tech Wabag witnesses turnaround in bottomline Q3FY18 Results: Va Tech Wabag witnesses turnaround in bottomline Amir Shaikh / Monday, February 12, 2018 0 3623 Article rating: 5.0 During the quarter, the company witnessed turnaround in net profit to Rs. 35.83 crore as against Rs. 0.37 crore net loss in the corresponding quarter of last year. Read more
IndoStar Capital files draft paper for Rs. 2,000 crore IPO IndoStar Capital files draft paper for Rs. 2,000 crore IPO Tanay Loya / Monday, February 12, 2018 0 2829 Article rating: 5.0 IndoStar Capital Finance, a non-banking finance company, has filed draft papers with Securities and Exchange Board of India to raise about Rs. 2,000 crore through an initial public offer (IPO). Read more